Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
EVL (mouse)

Overview
EVL Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. EVL enhances actin nucleation and polymerization. Required to transform actin polymerization into active movement for the propulsive force of Listeria monocytogenes. Belongs to the Ena/VASP family. 2 isoforms of the human protein are produced by alternative splicing. Note: This description may include information from UniProtKB.
Protein type: Motility/polarity/chemotaxis; Cytoskeletal protein
Cellular Component: cytoskeleton; cell projection; focal adhesion; lamellipodium; cytoplasm
Molecular Function: protein binding; actin binding; SH3 domain binding; profilin binding
Biological Process: platelet activation; axon guidance; positive regulation of actin filament polymerization; actin filament-based movement; actin polymerization and/or depolymerization; positive regulation of stress fiber formation; barbed-end actin filament capping; actin nucleation; protein homotetramerization
Reference #:  P70429 (UniProtKB)
Alt. Names/Synonyms: AI528774; Ena-vasodilator stimulated phosphoprotein; Ena/vasodilator-stimulated phosphoprotein-like; Ena/VASP-like protein; Evl
Gene Symbols: Evl
Molecular weight: 44,337 Da
Basal Isoelectric point: 8.92  Predict pI for various phosphorylation states
Select Structure to View Below

EVL

Protein Structure Not Found.


STRING  |  Reactome  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  UniProtKB  |  Entrez-Gene  |  Ensembl Gene


Modification Sites and Domains  

Modification Sites in Parent Protein, Orthologs, and Isoforms  
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       mouse

 
0 82 Y16-p ARASVMVyDDTSKKW
0 1 S20 VMVyDDTSKKWVPIK
0 10 Y39-p GFSRINIyHNTASST
0 1 S150 EQQHRQESLERRISA
1 3 S156 ESLERRISATGPILP
0 1 S169 LPPGHPSSAASTTLS
0 2 S240-p VQRPEDAsGGssPsG
0 2 S243-p PEDAsGGssPsGTSK
0 6 S244-p EDAsGGssPsGTSKS
0 1 S246-p AsGGssPsGTSKSDA
0 5 S257-p KSDANRAssGGGGGG
0 1 S258-p SDANRAssGGGGGGL
0 2 S281-p AKRRKAAsQTDKPAD
0 1 S294 ADRKEDESQTEDPsT
0 1 S300-p ESQTEDPsTsPsPGt
0 1 T301 SQTEDPsTsPsPGtR
0 29 S302-p QTEDPsTsPsPGtRA
0 5 S304-p EDPsTsPsPGtRATS
0 1 T307-p sTsPsPGtRATSQPP
0 1 S311 sPGtRATSQPPNSSE
0 21 S327-p GRKPWERsNsVEKPV
0 76 S329-p KPWERsNsVEKPVSS
0 6 S335 NsVEKPVSSLLsRtP
0 7 S336 sVEKPVSSLLsRtPs
0 18 S339-p KPVSSLLsRtPsVAK
0 17 T341-p VSSLLsRtPsVAKsP
0 65 S343-p SLLsRtPsVAKsPEA
0 75 S347-p RtPsVAKsPEAKsPL
0 28 S352-p AKsPEAKsPLQSQPH
0 4 S356 EAKsPLQSQPHSRVK
0 1 S360 PLQSQPHSRVKPAGs
0 18 S367-p SRVKPAGsVNDVGLD
  human

 
Y16-p ARASVMVyDDTsKKW
S20-p VMVyDDTsKKWVPIK
Y39-p GFSRINIyHNTASNT
S152-p HQQQRQEsLERRTsA
S158-p EsLERRTsATGPILP
S171-p LPPGHPSsAASAPVS
S242-p VQRPEDAsGGSsPSG
S245 PEDAsGGSsPSGTSK
S246-p EDAsGGSsPSGTSKS
S248 AsGGSsPSGTSKSDA
S259-p KSDANRAsSGGGGGG
S260 SDANRAsSGGGGGGL
S283-p AKRRKAAsQSDKPAE
S296-p AEKKEDEsQMEDPst
S302-p EsQMEDPstsPsPGT
T303-p sQMEDPstsPsPGTR
S304-p QMEDPstsPsPGTRA
S306-p EDPstsPsPGTRAAs
T309 stsPsPGTRAAsQPP
S313-p sPGTRAAsQPPNSSE
S329-p GRKPWERsNsVEKPV
S331-p KPWERsNsVEKPVss
S337-p NsVEKPVssILsRtP
S338-p sVEKPVssILsRtPs
S341-p KPVssILsRtPsVAK
T343-p VssILsRtPsVAKsP
S345-p sILsRtPsVAKsPEA
S349-p RtPsVAKsPEAKsPL
S354-p AKsPEAKsPLQsQPH
S358-p EAKsPLQsQPHsRMK
S362-p PLQsQPHsRMKPAGs
S369-p sRMKPAGsVNDMALD
  rat

 
Y16 ARASVMVYDDTSKKW
S20 VMVYDDTSKKWVPIK
Y39 GFSRINIYHNTASNT
S150 EQQHRQESLERRISA
S156 ESLERRISATGPILP
S169 LPPGHPSSAASATFS
S240 VQRPEDASGGSSPSG
S243 PEDASGGSSPSGTSK
S244 EDASGGSSPSGTSKS
S246 ASGGSSPSGTSKSDA
S257 KSDANRASSGGGGGG
S258 SDANRASSGGGGGGL
S281 AKRRKAASQTDKPAD
N294 ADRKEDENQTEDPST
S300 ENQTEDPSTsPSPGS
T301 NQTEDPSTsPSPGSR
S302-p QTEDPSTsPSPGSRA
S304 EDPSTsPSPGSRATS
S307 STsPSPGSRATSQPP
S311 SPGSRATSQPPNSSE
S327 GRKPWERSNsVEKPV
S329-p KPWERSNsVEKPVSS
S335 NsVEKPVSSLLSRVK
S336 sVEKPVSSLLSRVKP
S339 KPVSSLLSRVKPAGS
- gap
- gap
- gap
- gap
- gap
- gap
S346 SRVKPAGSVNDVGLD
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.